A randomized, open-label, comparative study for Edoxaban and Enoxaparin/Warfarin vs Warfarin alone in subjects with Atrial Fibrillation who have undergone Electrical Cardioversion
Brief description of study
The purpose of this study is to compare edoxaban with warfarin to see if it is safe and effective in preventing thromboembolism (formation of a clot [thrombus] in a blood vessel that breaks loose and is carried by the blood stream to block another vessel) and strokes which results when a brain blood vessel becomes blocked by a clot and in patients with AF who have undergone electrical cardioversion.
Detailed description of study
The purpose of this study is to compare edoxaban with warfarin to see if it is safe and effective in preventing thromboembolism (formation of a clot [thrombus] in a blood vessel that breaks loose and is carried by the blood stream to block another vessel) and strokes which results when a brain blood vessel becomes blocked by a clot and in patients with Atrial fibrillation who have undergone electrical cardioversion.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Atrial Fibrillation,electrical cardioversion,ablation,atrial fibrillation,ablation,electrical cardioversion,electrical cardioversion,ablation,electrical cardioversion,ablation
-
Age: Between 1 Years - 99 Years
-
Gender: All
Updated on
07 Sep 2022.
Study ID: 820126